C1q Binding Assessment
Creative Biolabs is committed to providing highly customized comprehensive solutions with the best quality to advance our global clients’ projects.
Description
Creative Biolabs is dedicated to the ongoing exploration and advancement of therapeutic antibodies. Our dedicated scientific team developed an advanced C1q binding assay platform to deliver exceptional service in antibody function validation, focusing on a thorough analysis of Fc characteristics related to CDC activity.
For more: https://www.creative-biolabs.com/c1q-binding-assessment-service.html
Researcher background
Complement-dependent cytotoxicity (CDC) is a crucial non-cellular mechanism in antibody therapies against cancer and infections, particularly microbial invasions.
Are you seeking volunteer growers or other types of volunteers?
Yes, seeking volunteer growers
Is this a multi-year project?
Yes
Researcher Location
11967
United States